Marketdash
Back to News

Wall Street Analysts Shake Things Up: Alphabet Gets 12% Upside, Honeywell Downgraded

MarketDash Editorial Team
20 days ago
Top Wall Street analysts made significant moves on Tuesday, with Alphabet earning a Buy upgrade and a price target suggesting over 12% upside potential. Meanwhile, Honeywell faced a sharp downgrade to Underperform as analysts reassessed their outlook across multiple sectors.

Wall Street analysts were busy on Tuesday reshuffling their ratings and price targets across a diverse range of companies. The moves included notable upgrades for tech giant Alphabet and energy companies, while industrial stalwart Honeywell faced a significant downgrade.

The Headline Grabber: Alphabet's Upgrade

The most attention-grabbing move came from Loop Capital analyst Rob Sanderson, who upgraded Alphabet Inc. (GOOGL) from Hold to Buy and raised the price target from $260 to $320. With Alphabet shares settling at $285.02 on Monday, that new target suggests upside potential of more than 12%. The upgrade signals renewed confidence in the tech giant's prospects.

Healthcare Stocks See Mixed Action

In the healthcare sector, analysts delivered a mix of bullish price target increases and more cautious adjustments. HC Wainwright analyst Robert Burns raised Zymeworks Inc. (ZYME) price target from $26 to $32 while maintaining a Buy rating. Zymeworks closed at $23.90 on Monday, putting the stock well below even the previous target.

Not all healthcare news was positive. BTIG analyst David Larsen slashed the price target for LifeMD Inc. (LFMD) from $18 to $10, though he maintained a Buy rating. With LifeMD shares closing at just $4.73 on Monday, the stock is trading well below even the reduced target. Similarly, Canaccord Genuity analyst Caitlin Cronin cut TELA Bio Inc. (TELA) price target from $7 to $4 while keeping a Buy rating. TELA Bio shares closed at $1.14 on Monday.

Energy Sector Gets Some Love

Energy stocks received more favorable treatment from analysts. Jefferies analyst Julien Dumoulin-Smith upgraded Legence Corp (LGN) from Hold to Buy and boosted the price target from $39 to $49. Legence shares closed at $40.12 on Monday, making this upgrade particularly timely for investors.

The same analyst also upgraded AES Corp (AES) from Underperform to Hold, while raising the price target from $12 to $13. AES shares settled at $13.92 on Monday, already trading above the new price target.

Tech and Crypto Exposure

HC Wainwright analyst Mike Colonnese increased the price target for HIVE Digital Technologies Ltd. (HIVE) from $8 to $10 while maintaining a Buy rating. HIVE Digital Technologies shares closed at $3.56 on Monday, representing a significant gap to the analyst's target price.

Real Estate Gets an Upgrade

Barclays analyst Richard Hightower made a notable move in the real estate sector, upgrading Regency Centers Corp (REG) from Equal-Weight to Overweight. The price target was modestly reduced from $83 to $82, but the rating upgrade suggests increased conviction. Regency Centers shares closed at $69.13 on Monday.

The Downgrades

Two companies faced downgrades from analysts. JP Morgan analyst Joseph Giordano downgraded Auna SA (AUNA) from Overweight to Neutral and cut the price target from $13.50 to $6. Auna shares closed at $5.00 on Monday, already below the reduced target.

The most significant downgrade came from Bank of America Securities analyst Andrew Obin, who cut Honeywell International Inc. (HON) from Buy to Underperform. The price target was slashed from $265 to $205. Honeywell shares closed at $196.08 on Monday, trading below even the reduced target and suggesting the analyst sees limited near-term upside for the industrial conglomerate.

What It All Means

These rating changes reflect how analysts are reassessing company prospects as market conditions evolve. The Alphabet upgrade stands out as a vote of confidence in big tech, while the Honeywell downgrade suggests concerns about industrial sector headwinds. The energy sector upgrades indicate analysts see improving fundamentals there, while healthcare stocks continue to face scrutiny with mixed price target adjustments.

For investors, analyst ratings represent one data point among many to consider when making investment decisions. Price targets, in particular, should be viewed as estimates rather than guarantees, especially when current trading prices sit far below or above those targets.

Back to News

Wall Street Analysts Shake Things Up: Alphabet Gets 12% Upside, Honeywell Downgraded

MarketDash Editorial Team
20 days ago
Top Wall Street analysts made significant moves on Tuesday, with Alphabet earning a Buy upgrade and a price target suggesting over 12% upside potential. Meanwhile, Honeywell faced a sharp downgrade to Underperform as analysts reassessed their outlook across multiple sectors.

Wall Street analysts were busy on Tuesday reshuffling their ratings and price targets across a diverse range of companies. The moves included notable upgrades for tech giant Alphabet and energy companies, while industrial stalwart Honeywell faced a significant downgrade.

The Headline Grabber: Alphabet's Upgrade

The most attention-grabbing move came from Loop Capital analyst Rob Sanderson, who upgraded Alphabet Inc. (GOOGL) from Hold to Buy and raised the price target from $260 to $320. With Alphabet shares settling at $285.02 on Monday, that new target suggests upside potential of more than 12%. The upgrade signals renewed confidence in the tech giant's prospects.

Healthcare Stocks See Mixed Action

In the healthcare sector, analysts delivered a mix of bullish price target increases and more cautious adjustments. HC Wainwright analyst Robert Burns raised Zymeworks Inc. (ZYME) price target from $26 to $32 while maintaining a Buy rating. Zymeworks closed at $23.90 on Monday, putting the stock well below even the previous target.

Not all healthcare news was positive. BTIG analyst David Larsen slashed the price target for LifeMD Inc. (LFMD) from $18 to $10, though he maintained a Buy rating. With LifeMD shares closing at just $4.73 on Monday, the stock is trading well below even the reduced target. Similarly, Canaccord Genuity analyst Caitlin Cronin cut TELA Bio Inc. (TELA) price target from $7 to $4 while keeping a Buy rating. TELA Bio shares closed at $1.14 on Monday.

Energy Sector Gets Some Love

Energy stocks received more favorable treatment from analysts. Jefferies analyst Julien Dumoulin-Smith upgraded Legence Corp (LGN) from Hold to Buy and boosted the price target from $39 to $49. Legence shares closed at $40.12 on Monday, making this upgrade particularly timely for investors.

The same analyst also upgraded AES Corp (AES) from Underperform to Hold, while raising the price target from $12 to $13. AES shares settled at $13.92 on Monday, already trading above the new price target.

Tech and Crypto Exposure

HC Wainwright analyst Mike Colonnese increased the price target for HIVE Digital Technologies Ltd. (HIVE) from $8 to $10 while maintaining a Buy rating. HIVE Digital Technologies shares closed at $3.56 on Monday, representing a significant gap to the analyst's target price.

Real Estate Gets an Upgrade

Barclays analyst Richard Hightower made a notable move in the real estate sector, upgrading Regency Centers Corp (REG) from Equal-Weight to Overweight. The price target was modestly reduced from $83 to $82, but the rating upgrade suggests increased conviction. Regency Centers shares closed at $69.13 on Monday.

The Downgrades

Two companies faced downgrades from analysts. JP Morgan analyst Joseph Giordano downgraded Auna SA (AUNA) from Overweight to Neutral and cut the price target from $13.50 to $6. Auna shares closed at $5.00 on Monday, already below the reduced target.

The most significant downgrade came from Bank of America Securities analyst Andrew Obin, who cut Honeywell International Inc. (HON) from Buy to Underperform. The price target was slashed from $265 to $205. Honeywell shares closed at $196.08 on Monday, trading below even the reduced target and suggesting the analyst sees limited near-term upside for the industrial conglomerate.

What It All Means

These rating changes reflect how analysts are reassessing company prospects as market conditions evolve. The Alphabet upgrade stands out as a vote of confidence in big tech, while the Honeywell downgrade suggests concerns about industrial sector headwinds. The energy sector upgrades indicate analysts see improving fundamentals there, while healthcare stocks continue to face scrutiny with mixed price target adjustments.

For investors, analyst ratings represent one data point among many to consider when making investment decisions. Price targets, in particular, should be viewed as estimates rather than guarantees, especially when current trading prices sit far below or above those targets.